Literature DB >> 10943598

Activation of coagulation during treatment with haemodialysis.

P C Bartels1, M Schoorl, M Schoorl, J G Wiering, M J Nubé.   

Abstract

Generation of factor XII, thrombin antithrombin complexes, prothrombin fragment 1+2 and thrombus precursor protein has been monitored in 16 subjects during haemodialysis. Immediately after starting treatment, contact of blood with the negatively charged surfaces of the polyacrylnitril membrane AN-69 resulted in a 9-45% decrease in factor XII activity. Peak concentrations for thrombin antithrombin complexes (50 to 120 microg/L) were observed 30 min after the start of haemodialysis. Establishment of thrombus precursor protein concentrations yielded steadily increasing results without any tendency to decrease during treatment. Determination of thrombin antithrombin complexes is considered to establish the most sensitive short-term reacting parameter indicating activation of coagulation. A steady generation of fibrin and fibrinogen-fibrin complexes during treatment with haemodialysis is indicated by increasing results for thrombus precursor protein. In order to prevent clotting during haemodialysis, an additional supplementation of anticoagulant is needed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943598     DOI: 10.1080/003655100750046440

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

Review 1.  The Biology of Hemodialysis Vascular Access Failure.

Authors:  Akshaar Brahmbhatt; Sanjay Misra
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

2.  Bleeding risk of haemodialysis and peritoneal dialysis patients.

Authors:  Anita van Eck van der Sluijs; Alferso C Abrahams; Maarten B Rookmaaker; Marianne C Verhaar; Willem Jan W Bos; Peter J Blankestijn; Friedo W Dekker; Merel van Diepen; Gurbey Ocak
Journal:  Nephrol Dial Transplant       Date:  2021-01-01       Impact factor: 5.992

Review 3.  Oxidative stress: An essential factor in the process of arteriovenous fistula failure.

Authors:  Ke Hu; Yi Guo; Yuxuan Li; Chanjun Lu; Chuanqi Cai; Shunchang Zhou; Zunxiang Ke; Yiqing Li; Weici Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-11

4.  Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis.

Authors:  James A Milburn; Isobel Ford; Nicola J Mutch; Nicholas Fluck; Julie Brittenden
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

5.  Coagulation activation, depletion of platelet granules and endothelial integrity in case of uraemia and haemodialysis treatment.

Authors:  Marianne Schoorl; Margreet Schoorl; Menso J Nubé; Piet C M Bartels
Journal:  BMC Nephrol       Date:  2013-03-27       Impact factor: 2.388

6.  Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.

Authors:  Luca Gabutti; Barbara Lucchini; Claudio Marone; Lorenzo Alberio; Michel Burnier
Journal:  BMC Nephrol       Date:  2009-03-05       Impact factor: 2.388

7.  Aspects of platelet disturbances in haemodialysis patients.

Authors:  Marianne Schoorl; Muriel P C Grooteman; Piet C M Bartels; Menso J Nubé
Journal:  Clin Kidney J       Date:  2013-03-29

8.  Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.

Authors:  Bruno Guéry; Corinne Alberti; Aude Servais; Elarbi Harrami; Lynda Bererhi; Brigitte Zins; Malik Touam; Dominique Joly
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

Review 9.  The molecular mechanisms of hemodialysis vascular access failure.

Authors:  Akshaar Brahmbhatt; Andrea Remuzzi; Marco Franzoni; Sanjay Misra
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.